SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020

被引:65
作者
Fischer, Bastian [1 ]
Knabbe, Cornelius [1 ]
Vollmer, Tanja [1 ]
机构
[1] Herz & Diabeteszentrum NRW, Inst Labs & Transfus Med, Bad Oeynhausen, Germany
关键词
D O I
10.2807/1560-7917.ES.2020.25.28.2001285
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Most cases of coronavirus disease 2019 are mild or asymptomatic. Therefore, many cases remain unrecorded. We determined seroprevalence of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 3,186 regular blood donors in three German federal states between 9 March and 3 June 2020. The IgG seroprevalence was 0.91% (95% confidence interval (CI): 0.58-1.24) overall, ranging from 0.66% (95% CI: 0.13-1.19) in Hesse to 1.22% (95% CI: 0.33-2.10) in Lower-Saxony.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 22 条
[1]   What policy makers need to know about COVID-19 protective immunity [J].
Altmann, Daniel M. ;
Douek, Daniel C. ;
Boyton, Rosemary J. .
LANCET, 2020, 395 (10236) :1527-1529
[2]  
[Anonymous], 2020, EUA Authorized Serology Test Performance
[3]  
[Anonymous], 2020, EVALUATION 9 COMMERC, DOI [DOI 10.1101/2020.04.09.20056325, 10.1101/2020.04.09.20056325]
[4]   Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village [J].
Day, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 :m1165
[5]   Covid-19: four fifths of cases are asymptomatic, China figures indicate [J].
Day, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 :m1375
[6]  
Debatin K, PREVALENCE COVID 19
[7]   Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe [J].
Flaxman, Seth ;
Mishra, Swapnil ;
Gandy, Axel ;
Unwin, H. Juliette T. ;
Mellan, Thomas A. ;
Coupland, Helen ;
Whittaker, Charles ;
Zhu, Harrison ;
Berah, Tresnia ;
Eaton, Jeffrey W. ;
Monod, Melodie ;
Ghani, Azra C. ;
Donnelly, Christl A. ;
Riley, Steven ;
Vollmer, Michaela A. C. ;
Ferguson, Neil M. ;
Okell, Lucy C. ;
Bhatt, Samir .
NATURE, 2020, 584 (7820) :257-+
[8]   Patterns of IgG and IgM antibody response in COVID-19 patients [J].
Liu, Xuemei ;
Wang, Jing ;
Xu, Xiaolei ;
Liao, Guojian ;
Chen, Yaokai ;
Hu, Chang-Hua .
EMERGING MICROBES & INFECTIONS, 2020, 9 (01) :1269-1274
[9]  
Long QX, 2020, NAT MED, V26, P845, DOI [10.1093/cid/ciaa344, 10.1038/s41591-020-0897-1]
[10]   Validation of a commercially available SARS-CoV-2 serological immunoassay [J].
Meyer, B. ;
Torriani, G. ;
Yerly, S. ;
Mazza, L. ;
Calame, A. ;
Arm-Vernez, I ;
Zimmer, G. ;
Agoritsas, T. ;
Stirnemann, J. ;
Spechbach, H. ;
Guessous, I ;
Stringhini, S. ;
Pugin, J. ;
Roux-Lombard, P. ;
Fontao, L. ;
Siegrist, C-A ;
Eckerle, I ;
Vuilleumier, N. ;
Kaiser, L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (10) :1386-1394